MP4OX meets Phase IIa endpoint

Sangart Inc. (San Diego, Calif.) said MP4OX met the primary endpoint of significantly reducing serum lactate levels from baseline to two hours vs. Ringer's lactate solution in a Phase IIa trial to tre...